Description

Glimax Tablets 3 mg. №60

Ingredients:

Glimax tablets 3 mg contain the active ingredient Glimepiride, which is a sulfonylurea that helps control blood sugar levels in patients with type 2 diabetes.

Dosage:

The recommended dosage of Glimax tablets is 3 mg once daily, preferably with breakfast or the first main meal of the day. Dosage may vary based on individual patient needs and response to treatment.

Indications:

Glimax tablets are indicated for the management of type 2 diabetes mellitus when diet and exercise alone are not sufficient to control blood sugar levels.

Contraindications:

Do not use Glimax tablets if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, or a history of an allergic reaction to sulfonylureas.

Directions:

Take Glimax tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water. Monitor blood sugar levels regularly as directed.

Scientific Evidence:

Studies have shown that Glimepiride, the active ingredient in Glimax tablets, effectively lowers blood sugar levels by stimulating the release of insulin from the pancreas. Research published in the Journal of Diabetes Research demonstrated the efficacy of Glimepiride in improving glycemic control in patients with type 2 diabetes.

Additional Information:

It is important to follow a healthy diet and exercise regimen while taking Glimax tablets to achieve optimal results in managing diabetes. Contact your healthcare provider if you experience any unusual symptoms or side effects while using this medication.

Pharmacologically, Glimepiride works by binding to specific receptors on pancreatic beta cells, leading to an increase in insulin release. This helps lower blood sugar levels by facilitating the uptake of glucose into cells for energy production.

Clinical trials comparing the effectiveness of Glimepiride with other antidiabetic medications have shown favorable results in terms of glycemic control and overall safety profile. A meta-analysis published in the Journal of Clinical Pharmacy and Therapeutics concluded that Glimepiride is a valuable option for the treatment of type 2 diabetes due to its efficacy and tolerability.